Focusing on histopathological features, the two different tumour phenotypes (SFT and HPC) were not specifically associated with clinical variables (gender, age and tumour site): as a matter of fact, a distinction based on their clinico-radiological characteristics was not deemed possible even when they were considered different entities.[ 29 ] The HPC phenotype was associated with a higher mitotic count, but tumour phenotype alone did not reach statistical significance in terms of DFI; on the contrary, a higher WHO grade was associated with a worse outcome.
← all excerpts
Pathological prognostic markers in central nervous system solitary fibrous tumour/hemangiopericytoma: Evidence from a small series.
1
—
—